| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 19, 2003
From the Departments of Radiology (W.Y., J.J.S., J.K.K., J.G.P., H.K.K.) and Neurology (K.H.C.), Chonnam National University Medical School, Chonnam National University Hospital, Dong-gu, Gwangju, South Korea. * To whom correspondence should be addressed. E-mail: radyoon{at}cnuh.com.
Background and Purpose--The goal of this study was to determine the CT findings and clinical consequences of contrast enhancement and contrast extravasation on CT scans obtained after intra-arterial thrombolytic therapy for treatment of acute ischemic stroke. Methods--Sixty-two patients were treated with intra-arterial thrombolysis. All patients underwent nonenhanced CT scans immediately and 24 hours after thrombolytic therapy. Contrast enhancement was defined as a hyperdense lesion that disappeared on a 24-hour follow-up CT scan. Contrast extravasation was defined as a hyperdense lesion with maximum Hounsfield unit >90 that persisted on a follow-up CT scan. We evaluated the differences in the clinical and radiological data between 3 groups: contrast enhancement, contrast extravasation, and control groups. Results--Contrast enhancement was found in 14 of 62 patients (22.6%); contrast extravasation was seen in 7 (11.3%). Compared with the control group, the contrast enhancement group had a lower recanalization grade (64.3% versus 34.1%, P=0.048) and a lower incidence of hemorrhagic transformation (14.3% versus 43.9%, P=0.047). The contrast extravasation group had a higher incidence of both hemorrhage (100% versus 43.9%, P=0.006) and symptomatic hemorrhage (100% versus 14.6%, P<0.001) than the control group. Poor outcomes were more frequent in the contrast extravasation group (100% versus 38.9%, P=0.003) than the control group. Conclusions--Contrast enhancement on CT scans obtained after intra-arterial thrombolysis is usually not associated with hemorrhagic complications. However, contrast extravasation is highly associated with parenchymatous hematoma and should be considered a negative prognostic sign.
Accepted on December 22, 2003
Contrast Enhancement and Contrast Extravasation on Computed Tomography After Intra-Arterial Thrombolysis in Patients With Acute Ischemic Stroke
Woong Yoon MD*;
This article has been cited by other articles:
![]() |
R. I. Aviv, C. D. d'Esterre, B. D. Murphy, J. J. Hopyan, B. Buck, G. Mallia, V. Li, L. Zhang, S. P. Symons, and T.-Y. Lee Hemorrhagic Transformation of Ischemic Stroke: Prediction with CT Perfusion Radiology, March 1, 2009; 250(3): 867 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Khatri, J. P. Broderick, J. C. Khoury, J. A. Carrozzella, T. A. Tomsick, and for the IMS I and II Investigators Microcatheter Contrast Injections During Intra-Arterial Thrombolysis May Increase Intracranial Hemorrhage Risk Stroke, December 1, 2008; 39(12): 3283 - 3287. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tomsick, J. Broderick, J. Carrozella, P. Khatri, M. Hill, Y. Palesch, J. Khoury, and for the Interventional Management of Stroke II Inv Revascularization Results in the Interventional Management of Stroke II Trial AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 582 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Brisman, M. Jilani, and J.S. McKinney Contrast Enhancement Hyperdensity After Endovascular Coiling of Intracranial Aneurysms AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 588 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Khatri, L. R. Wechsler, and J. P. Broderick Intracranial Hemorrhage Associated With Revascularization Therapies Stroke, February 1, 2007; 38(2): 431 - 440. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |